Treace Medical Concepts Inc
NASDAQ:TMCI
Cash Flow Statement
Cash Flow Statement
Treace Medical Concepts Inc
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(12)
|
(21)
|
(27)
|
(39)
|
(45)
|
(43)
|
(47)
|
(42)
|
(48)
|
(50)
|
(55)
|
(64)
|
(62)
|
(56)
|
(53)
|
(49)
|
(50)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
8
|
9
|
9
|
10
|
|
| Stock-Based Compensation |
2
|
3
|
4
|
6
|
7
|
8
|
9
|
11
|
14
|
17
|
22
|
25
|
28
|
31
|
32
|
35
|
35
|
|
| Other Non-Cash Items |
2
|
4
|
5
|
11
|
14
|
16
|
18
|
14
|
17
|
19
|
23
|
29
|
31
|
36
|
38
|
39
|
40
|
|
| Cash Interest Paid |
3
|
4
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Change in Working Capital |
(2)
|
(1)
|
(3)
|
(4)
|
1
|
(6)
|
(14)
|
(14)
|
(14)
|
(10)
|
0
|
(3)
|
(10)
|
(25)
|
(19)
|
(14)
|
(12)
|
|
| Cash from Operating Activities |
(13)
N/A
|
(17)
-37%
|
(24)
-39%
|
(31)
-29%
|
(29)
+6%
|
(31)
-6%
|
(41)
-33%
|
(38)
+6%
|
(40)
-5%
|
(35)
+15%
|
(25)
+29%
|
(30)
-23%
|
(32)
-8%
|
(37)
-15%
|
(26)
+31%
|
(15)
+42%
|
(12)
+18%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(1)
|
(3)
|
(4)
|
(8)
|
(13)
|
(15)
|
(15)
|
(14)
|
(12)
|
(11)
|
(14)
|
(11)
|
(11)
|
(12)
|
(11)
|
(14)
|
(14)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(62)
|
(141)
|
(147)
|
(139)
|
(70)
|
17
|
47
|
48
|
47
|
41
|
18
|
21
|
|
| Cash from Investing Activities |
(1)
N/A
|
(3)
-138%
|
(4)
-47%
|
(8)
-113%
|
(13)
-58%
|
(77)
-471%
|
(156)
-103%
|
(161)
-3%
|
(150)
+6%
|
(81)
+46%
|
3
N/A
|
36
+1 118%
|
37
+3%
|
35
-4%
|
30
-16%
|
4
-86%
|
7
+74%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
108
|
109
|
110
|
3
|
3
|
2
|
109
|
110
|
110
|
109
|
2
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Net Issuance of Debt |
(2)
|
(2)
|
0
|
20
|
20
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
107
N/A
|
108
+1%
|
110
+2%
|
21
-81%
|
22
+1%
|
21
-3%
|
127
+512%
|
110
-14%
|
110
0%
|
109
0%
|
1
-99%
|
0
-66%
|
0
-34%
|
0
-46%
|
0
-61%
|
1
+1 073%
|
1
-2%
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
93
N/A
|
88
-6%
|
82
-6%
|
(18)
N/A
|
(21)
-16%
|
(86)
-313%
|
(69)
+20%
|
(89)
-30%
|
(81)
+9%
|
(6)
+92%
|
(20)
-212%
|
6
N/A
|
5
-21%
|
(2)
N/A
|
4
N/A
|
(10)
N/A
|
(4)
+56%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(14)
N/A
|
(20)
-45%
|
(28)
-41%
|
(39)
-41%
|
(42)
-8%
|
(45)
-7%
|
(56)
-22%
|
(52)
+6%
|
(52)
+1%
|
(46)
+11%
|
(38)
+16%
|
(42)
-8%
|
(43)
-4%
|
(49)
-13%
|
(37)
+24%
|
(29)
+21%
|
(26)
+10%
|
|